NCT03225196View on ClinicalTrials.gov

Extracellular RNAs in Relation to Cardiometabolic Risk

CompletedOBSERVATIONAL
Enrollment

4,495

Participants

Timeline

Start Date

July 17, 2017

Primary Completion Date

June 11, 2020

Study Completion Date

June 11, 2020

Conditions
Subclinical Atherosclerotic Cardiovascular DiseaseBlood PressureObesity
Trial Locations (1)

01702

Framingham Heart Study, Framingham

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT03225196 - Extracellular RNAs in Relation to Cardiometabolic Risk | Biotech Hunter | Biotech Hunter